Eperisone
Eperisone is a prescription antispasmodic drug used to treat muscle spasms. When taken as the hydrochloride salt, it helps relax both skeletal muscles and certain blood vessel muscles. This can reduce myotonia (muscle stiffness), improve blood flow, and lower the reflex of pain. By easing pain, lack of blood flow, and muscle tension, it helps stiffness and stiffness-related movement problems and makes it easier to move.
It may also help relieve dizziness and ringing in the ears that can occur with some brain or neck (cervical) problems. Eperisone tends to cause less drowsiness than many other antispasmodics, so it can be easier to use when you need to stay alert. It can help you move your arms and legs more easily without weakening muscle strength, which is useful during early rehabilitation and ongoing therapy.
Forms and brand names
- Eperisone hydrochloride is sold under names such as Myonal and Epry.
- Common forms: 50 mg sugar-coated tablets and 10% oral granules.
- A transdermal (skin) patch is being developed and has shown promise in lab studies, but it is not yet available for patients.
How it is taken
- For adults, the usual dose is 50–150 mg per day, taken in divided doses after meals.
- The dose is adjusted by the doctor based on symptom severity, age, and response.
- It is not established as safe for children, so pediatric use is not recommended at this time.
- In older adults, a lower dose and careful monitoring are advised.
Safety, side effects, and warnings
- Possible side effects (in rare cases): overly relaxed muscles, stomach upset, nausea, dizziness, drowsiness, skin rashes, diarrhea, vomiting, indigestion, insomnia, headache, and constipation.
- Caution in people with liver problems, as it may worsen liver issues.
- If you feel very weak, dizzy, or sleepy, tell your doctor—the dose may need to be reduced or the treatment stopped.
- Do not drive or operate heavy machinery if you feel impaired.
- Allergic reactions to the drug are a reason to avoid it.
- There have been rare reports of eye focusing problems when used with related drugs, and a few cases of seizures after accidental ingestion by a child.
- Pregnant or breastfeeding women should avoid use: not enough evidence of safety in pregnancy, and breastfeeding should be stopped during treatment.
Other notes
- Eperisone has very low oral bioavailability because much is metabolized in the intestine before it reaches the bloodstream. Researchers are exploring a patch to provide longer-lasting effects (over 24 hours) compared with 1–2 hours after an oral dose.
- Some early research has explored using eperisone or related drugs as blood pressure–lowering agents in animals; more studies are needed.
Availability
- Marketed worldwide under various brand names.
This page was last edited on 3 February 2026, at 05:49 (CET).